Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 have?
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 has 1,115 citations in the OpenAlex counts ScholarIQ stores.
When was Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 published?
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 has 2020 year in the ScholarIQ index.
What is the open-access status of Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19?
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 has green oa status in the ScholarIQ index.
What is the DOI of Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19?
The DOI for Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 is on the source record.
What is the PMID of Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19?
The PMID for Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 is on the source record.
What is the OpenAlex record for Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19?
The OpenAlex for Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 is on the source record.